156 related articles for article (PubMed ID: 20859436)
21. Priority setting in hospitals: fairness, inclusiveness, and the problem of institutional power differences.
Gibson JL; Martin DK; Singer PA
Soc Sci Med; 2005 Dec; 61(11):2355-62. PubMed ID: 15950347
[TBL] [Abstract][Full Text] [Related]
22. Drug formulary decision-making in two regional health authorities in British Columbia, Canada.
Armstrong K; Mitton C; Carleton B; Shoveller J
Health Policy; 2008 Dec; 88(2-3):308-16. PubMed ID: 18508151
[TBL] [Abstract][Full Text] [Related]
23. Improving district level health planning and priority setting in Tanzania through implementing accountability for reasonableness framework: Perceptions of stakeholders.
Maluka S; Kamuzora P; San Sebastián M; Byskov J; Ndawi B; Hurtig AK
BMC Health Serv Res; 2010 Dec; 10():322. PubMed ID: 21122123
[TBL] [Abstract][Full Text] [Related]
24. Formulary management in the Department of Defense.
Trice S; Devine J; Mistry H; Moore E; Linton A
J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
[TBL] [Abstract][Full Text] [Related]
25. Decentralized health care priority-setting in Tanzania: evaluating against the accountability for reasonableness framework.
Maluka S; Kamuzora P; San Sebastiån M; Byskov J; Olsen ØE; Shayo E; Ndawi B; Hurtig AK
Soc Sci Med; 2010 Aug; 71(4):751-9. PubMed ID: 20554365
[TBL] [Abstract][Full Text] [Related]
26. To fund or not to fund: development of a decision-making framework for the coverage of new health technologies.
Stafinski T; Menon D; McCabe C; Philippon DJ
Pharmacoeconomics; 2011 Sep; 29(9):771-80. PubMed ID: 21756008
[TBL] [Abstract][Full Text] [Related]
27. Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT).
van Lent LGG; Stoel NK; van Weert JCM; van Gurp J; de Jonge MJA; Lolkema MP; Gort EH; Pulleman SM; Oomen-de Hoop E; Hasselaar J; van der Rijt CCD
BMC Palliat Care; 2019 Nov; 18(1):106. PubMed ID: 31783851
[TBL] [Abstract][Full Text] [Related]
28. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
[TBL] [Abstract][Full Text] [Related]
29. Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions.
Gauvreau CL; Wight L; Subasri M; Palmer A; Hayeems R; Croker A; Abelson J; Fraser B; Bombard Y; Moore Hepburn C; Wilson MG; Denburg A
Health Expect; 2023 Apr; 26(2):715-727. PubMed ID: 36639959
[TBL] [Abstract][Full Text] [Related]
30. Adoption of an innovation to repair aortic aneurysms at a Canadian hospital: a qualitative case study and evaluation.
Danjoux NM; Martin DK; Lehoux PN; Harnish JL; Shaul RZ; Bernstein M; Urbach DR
BMC Health Serv Res; 2007 Nov; 7():182. PubMed ID: 18005409
[TBL] [Abstract][Full Text] [Related]
31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
32. Priority setting in a hospital drug formulary: a qualitative case study and evaluation.
Martin DK; Hollenberg D; MacRae S; Madden S; Singer P
Health Policy; 2003 Dec; 66(3):295-303. PubMed ID: 14637013
[TBL] [Abstract][Full Text] [Related]
33. Justice and procedure: how does "accountability for reasonableness" result in fair limit-setting decisions?
Rid A
J Med Ethics; 2009 Jan; 35(1):12-6. PubMed ID: 19103936
[TBL] [Abstract][Full Text] [Related]
34. Implementing CER: what will it take?
Biskupiak JE; Dunn JD; Holtorf AP
J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S19-29. PubMed ID: 22663296
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of clinician input in Canadian funding decisions for cancer drugs: a cross-sectional study based on CADTH reimbursement recommendations.
Jenei K; Meyers DE
BMJ Open; 2023 Oct; 13(10):e066378. PubMed ID: 37844982
[TBL] [Abstract][Full Text] [Related]
36. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
37. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
[TBL] [Abstract][Full Text] [Related]
38. SARS and hospital priority setting: a qualitative case study and evaluation.
Bell JA; Hyland S; DePellegrin T; Upshur RE; Bernstein M; Martin DK
BMC Health Serv Res; 2004 Dec; 4(1):36. PubMed ID: 15606924
[TBL] [Abstract][Full Text] [Related]
39. Fairness, accountability for reasonableness, and the views of priority setting decision-makers.
Martin DK; Giacomini M; Singer PA
Health Policy; 2002 Sep; 61(3):279-90. PubMed ID: 12098521
[TBL] [Abstract][Full Text] [Related]
40. Conceptualizations of fairness and legitimacy in the context of Ethiopian health priority setting: Reflections on the applicability of accountability for reasonableness.
Petricca K; Bekele A
Dev World Bioeth; 2018 Dec; 18(4):357-364. PubMed ID: 28544136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
